Ascendia Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Ascendia Pharmaceuticals's estimated annual revenue is currently $20.7M per year.
- Ascendia Pharmaceuticals's estimated revenue per employee is $201,000
- Ascendia Pharmaceuticals's total funding is $20M.
Employee Data
- Ascendia Pharmaceuticals has 103 Employees.
- Ascendia Pharmaceuticals grew their employee count by 1% last year.
Ascendia Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP Business Development | Reveal Email/Phone |
2 | Director Engineering and Facilities | Reveal Email/Phone |
3 | Chief Business Officer | Reveal Email/Phone |
4 | Director Business Development | Reveal Email/Phone |
5 | Senior Director | Reveal Email/Phone |
6 | Senior Director Business Development | Reveal Email/Phone |
7 | Senior Formulation Scientist | Reveal Email/Phone |
8 | Senior Scientist | Reveal Email/Phone |
9 | Senior Scientist | Reveal Email/Phone |
10 | Senior Director Business Development | Reveal Email/Phone |
Ascendia Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.6M | 33 | 32% | N/A | N/A |
#2 | $38M | 189 | 6% | N/A | N/A |
#3 | $6.6M | 33 | 22% | N/A | N/A |
#4 | $4180M | 15242 | 1% | $550M | N/A |
#5 | $17.5M | 87 | 50% | N/A | N/A |
#6 | $6.7M | 125 | -37% | $199.6M | N/A |
#7 | $10.9M | 54 | 15% | N/A | N/A |
#8 | $15.3M | 76 | 33% | N/A | N/A |
#9 | $128.6M | 640 | 16% | N/A | N/A |
#10 | $18.7M | 93 | 21% | N/A | N/A |
What Is Ascendia Pharmaceuticals?
Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceuticals is your ideal partner for: · Early stage IND-enabling formulations for toxicology and pharmacokinetic (PK) studies · Rapid development through Phase I CTM materials for oral and parenteral dosage forms · Fast discovery formulation support · Formulation development and CTM manufacturing for specialty pharmaceuticals Ascendia Pharmaceuticals also provides special development programs: · Formulations for poorly soluble and low bioavailability drugs · First-in-man injectable formulations · Nano-emulsion and nano-particle formulations · Peptide formulations · Sustained release by parenteral or oral routes · Development of 505(b)(2) products · Development of complex generics · High potency and DEA controlled drug substances · Ocular formulation development · Animal health formulations
keywords:N/A
$20M
Total Funding
103
Number of Employees
$20.7M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in North Brunswick
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 112 | 15% | N/A |
#2 | $16.2M | 112 | -3% | N/A |
#3 | $16.5M | 114 | -27% | N/A |
#4 | $30.8M | 114 | 1% | N/A |
#5 | $17.5M | 121 | 3% | N/A |